Table 2. Baseline outcomes for all participants by intervention and control group.
Variable (range) ^ | Intervention Baseline (N = 76) | Control Baseline (N = 79) |
|||
---|---|---|---|---|---|
Mean (SD) | Mean (SD) | P-value | |||
Average pain (0–10) | 7 (1.9) | 7 (1.9) | 0.97 | ||
BPI Interference (0–10) | 7 (2.2) | 6 (2.3) | 0.47 | ||
BPI Severity (0–10) | 7 (1.9) | 7 (1.8) | 0.95 | ||
PHQ (0–27) | 13 (5.6) | 11 (5.3) | 0.11 | ||
Pain Self-Efficacy (0–60) | 30 (15.4) | 32 (13.5) | 0.47 | ||
Patient Activation Measure (0–100) | 60 (15.6) | 56 (11.8) | 0.05* | ||
SF-12 Physical Composite Score (0–100) | 33 (10.3) | 35 (10.6) | 0.12 | ||
SF-12 Mental Composite Score (0–100) | 35 (9.5) | 36 (10.3) | 0.62 | ||
Current Opioid Misuse Measure (0–64) | 11 (5.9) | 9 (5.8) | 0.05* | ||
N | % | N | % | P-value | |
Pain medication past 7 days | 67 | 88 | 65 | 82 | 0.30 |
Emergency Department Use | 15 | 21 | 11 | 14 | 0.28 |
*Significant differences between the intervention and control group for PAM (p = 0.0513), COMM (p = 0.0495) at a significant level of 0.1, so they were adjusted for in all subsequent models.
^Continuous variables are summarized with mean (standard deviation)